163 related articles for article (PubMed ID: 20091184)
1. The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study.
Wang X; Fu Y; Chen X; Ye J; Lü B; Ye F; Lü W; Xie X
J Cancer Res Clin Oncol; 2010 Jul; 136(7):989-96. PubMed ID: 20091184
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
3. Expression of differentiation associated protein Hes1 and Hes5 in cervical squamous carcinoma and its precursors.
Liu J; Ye F; Chen H; Lü W; Zhou C; Xie X
Int J Gynecol Cancer; 2007; 17(6):1293-9. PubMed ID: 17388915
[TBL] [Abstract][Full Text] [Related]
4. Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis.
Piscione TD; Wu MY; Quaggin SE
Gene Expr Patterns; 2004 Oct; 4(6):707-11. PubMed ID: 15465493
[TBL] [Abstract][Full Text] [Related]
5. [Expressions and clinical significances of paired box gene 2 and cyclin D1 in advanced ovarian serous carcinoma].
Song Y; Zuo J; Huang X; Shen GH; Liu XY; Zhang X
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):891-895. PubMed ID: 29262504
[No Abstract] [Full Text] [Related]
6. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.
Ohtsuka T; Ishibashi M; Gradwohl G; Nakanishi S; Guillemot F; Kageyama R
EMBO J; 1999 Apr; 18(8):2196-207. PubMed ID: 10205173
[TBL] [Abstract][Full Text] [Related]
7. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
Meng Q; Duan P; Li L; Miao Y
Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276
[TBL] [Abstract][Full Text] [Related]
8. Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion.
Davidson B; Smith Y; Nesland JM; Kærn J; Reich R; Tropè CG
Hum Pathol; 2013 Nov; 44(11):2449-60. PubMed ID: 24011953
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer.
Kujawa KA; Zembala-Nożyńska E; Cortez AJ; Kujawa T; Kupryjańczyk J; Lisowska KM
Cells; 2020 Jan; 9(1):. PubMed ID: 31936272
[TBL] [Abstract][Full Text] [Related]
10. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Stavnes HT; Holth A; Don T; Kærn J; Vaksman O; Reich R; Trope' CG; Davidson B
Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
[TBL] [Abstract][Full Text] [Related]
11. High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.
Miyamoto M; Takano M; Iwaya K; Shinomiya N; Goto T; Kato M; Suzuki A; Aoyama T; Hirata J; Nagaoka I; Tsuda H; Furuya K
Br J Cancer; 2015 Feb; 112(4):739-44. PubMed ID: 25628093
[TBL] [Abstract][Full Text] [Related]
12. Hes1/Hes5 gene inhibits differentiation via down-regulating Hash1 and promotes proliferation in cervical carcinoma cells.
Liu J; Lu WG; Ye F; Cheng XD; Hong D; Hu Y; Chen HZ; Xie X
Int J Gynecol Cancer; 2010 Oct; 20(7):1109-16. PubMed ID: 21495212
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy.
Abdelrahman AE; Fathy A; Elsebai EA; Nawar N; Etman WM
Ann Diagn Pathol; 2018 Aug; 35():27-37. PubMed ID: 30072015
[TBL] [Abstract][Full Text] [Related]
14. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.
Zhang J; Wang JC; Li YH; Wang RX; Fan XM
Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
[TBL] [Abstract][Full Text] [Related]
15. Hes1 and Hes5 activities are required for the normal development of the hair cells in the mammalian inner ear.
Zine A; Aubert A; Qiu J; Therianos S; Guillemot F; Kageyama R; de Ribaupierre F
J Neurosci; 2001 Jul; 21(13):4712-20. PubMed ID: 11425898
[TBL] [Abstract][Full Text] [Related]
16. Hes1 and Hes5 regulate vascular remodeling and arterial specification of endothelial cells in brain vascular development.
Kitagawa M; Hojo M; Imayoshi I; Goto M; Ando M; Ohtsuka T; Kageyama R; Miyamoto S
Mech Dev; 2013; 130(9-10):458-66. PubMed ID: 23871867
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of histological tumor regression (Böhm's score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma.
Rajkumar S; Polson A; Nath R; Lane G; Sayasneh A; Jakes A; Begum S; Mehra G
Gynecol Oncol; 2018 Nov; 151(2):264-268. PubMed ID: 30197060
[TBL] [Abstract][Full Text] [Related]
19. Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium.
Cau E; Gradwohl G; Casarosa S; Kageyama R; Guillemot F
Development; 2000 Jun; 127(11):2323-32. PubMed ID: 10804175
[TBL] [Abstract][Full Text] [Related]
20. HES1 and HES5 are dispensable for cartilage and endochondral bone formation.
Karlsson C; Brantsing C; Kageyama R; Lindahl A
Cells Tissues Organs; 2010; 192(1):17-27. PubMed ID: 20134146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
